已经打AZ疫苗的老年人别紧张,英国研究说AZ对老年人比辉瑞疫苗对重症更有效

billwanhua

本站元老
注册
2005-07-07
消息
16,715
荣誉分数
5,486
声望点数
373

"To make head to head comparisons, they have to be studied at the same time, in head-to-head trials," Adalja said.

That has not happened. Researchers studying the real-world use of Pfizer's and AstraZeneca's vaccines in Britain reported earlier this month that both lowered the risk of hospitalization and death in people 80 and older -- the group by far the most likely to die from infection.

The preprint study done by a team at the University of Bristol found the Pfizer/BioNTech vaccine was 71.4% effective in preventing hospitalizations and the Oxford/AstraZeneca vaccine was 80.4% effective in preventing hospitalizations in patients well into their 80s.

英国自己的研究,如果这个是真的,打了第一针没有血堵的还是打第二针吧
 
据我看到的报道,AZ保护率不错,严重不良反应也不高,除了印度生产的,确实有疫苗诱导发生血栓事件,如果超过一两个月没事,应当不会有血栓问题了。
 
据我看到的报道,AZ保护率不错,严重不良反应也不高,除了印度生产的,确实有疫苗诱导发生血栓事件,如果超过一两个月没事,应当不会有血栓问题了。
印度生产的,有啥问题,质检不够严格?
 
印度生产的,有啥问题,质检不够严格?
安省的严重不良反应报告统计,每十万剂,辉瑞和欧洲AZ1.2,M1.5-1.8,印度AZ略高,4-6。
 
后退
顶部